NewsPeople

SKAN Research Trust appoints Dr Paul Salins as Vice Chairman

Dr Salins is the Medical Director and Sr Vice President of Narayana Health – Mazumdar Shaw Medical Centre and also Managing Director, Mazumdar Shaw Medical Foundation

SKAN RESEARCH TRUST, founded by Ashok Soota, announced the appointment of Dr Paul Salins as Vice Chairman of the Trust. Dr Salins is the Medical Director and Sr Vice President of Narayana Health – Mazumdar Shaw Medical Centre and also Managing Director, Mazumdar Shaw Medical Foundation.

 With this appointment, the governance structure of SKAN will consist of:

  • Ashok Soota – Chairman & Managing Trustee
  • Davis Karedan – Vice Chairman & Trustee
  • Paul Salins – Vice Chairman

SKAN is India’s only not-for-profit medical research trust. The focus of SKAN is to work on transformational technologies changing the future of medicine. These include gut microbiome, human genomics, stem cells and bioinformatics/modelling. All these technologies will be applied to the areas of ageing and neurological ailments to achieve breakthrough therapies.

Ashok Soota, Chairman, SKAN, said, “We are delighted to have Paul as a key member of our Governance team and bring his vast expertise to the development of SKAN.”

Salins said, “I am delighted to be a member of the apex governance group in SKAN. I am impressed with the long-term orientation of SKAN and look forward to contributing to its Mission and 10-year goals.”

Dr Salins work on the systems approach to drug discovery to arrest or reverse lifestyle and ageing-related Chronic diseases early, during its continuum has led to a genre of “interceptive therapeutics”.

In the area of computation, Professor Salins terms his work “predictability before knowability” creating intuitive AI/machine learning systems for the analysis of large, complex data clusters and adaptive systems as the foundation for pattern-based topologic analytics and inverse kinematics. 

 

Support us in our endeavor to bring you Advertisement free content.
Choose your options to donate or subscribe.

Tags

Related Articles

Back to top button
Close
Close